In the current study, we employed human B cell lymphoma cell line BJAB as the scaffold to develop a cellular aAPC that could efficiently generate AFP-specific CTLs for adoptive immunotherapy of HCC [19]. Here, AFP is linked to hepatocellular carcinoma.